Neurology evidence, translated for clinical judgment.
Neurology® Podcast sits close to the working life of neurologists. Its episodes move through clinical trials, treatment guidance, publication practice, and disease-specific evidence with a steady focus on what changes in patient care.
PRESS PLAY
Neurology® Podcast is a clinical journal companion for people who want neurologic research translated without sanding off its complexity. It is measured from the start. A typical episode names a recent article, guideline, trial session, or editorial question, then lets a clinician or specialist explain why the issue matters beyond publication. The emphasis is rarely on novelty alone. It is on interpretation. Recent episodes examine Alzheimer disease prevention trials, including amyloid plaque-clearing antibody therapies and the policy questions that would follow if prevention data become persuasive. Another conversation works through antiseizure medication dosing during pregnancy and early postpartum, where physiologic changes, drug level monitoring, and gaps in daily clinical guidance all matter. Stroke coverage is similarly practical. Discussions of vascular neurology consider thrombectomy eligibility, perfusion imaging, anesthesia choices, regional stroke systems, and how new trial data might strain or improve care pathways. The show also looks upstream at how evidence reaches clinicians. A history of letters to the editor treats correspondence as a living part of scientific correction, criticism, and author response. Regulatory change gets the same careful treatment, with discussion of the FDA moving toward one pivotal trial as a default option and the uncertainty that creates for clinicians watching approval standards shift. The tone stays professional. Guests are given time to qualify claims, explain study design, and separate promising findings from established care. That patience is the point. Neurology® Podcast assumes its audience can follow names of trials, biomarkers, guideline classes, and clinical subspecialties, but it usually returns those details to a patient-facing question. What should be asked in clinic? What risk should be explained before a procedure? What does a normal exam miss when lived symptoms persist? Episodes on Ebola virus disease survivors in Liberia show that concern clearly, especially around the mismatch between neurologic assessments and reported day-to-day challenges. The series is not a broad wellness program. It is a working conversation for neurologists, trainees, and clinicians who need current evidence placed in context before it becomes routine practice.
Made for: Designed for neurologists, neurology trainees, clinical researchers, and other clinicians who are comfortable with technical medical discussion. It also suits listeners who follow neurologic trials, journal debate, and practice-changing evidence closely.
What sets it apart: Its strength is the disciplined move from peer-reviewed evidence to clinical application. Rather than simplifying every topic into general health advice, it preserves trial design, uncertainty, systems constraints, and patient care implications in the same conversation.
The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
Based on 5 episodes we listened to · September 2026
Neurology Podcast turns neurological research into focused questions about clinical decisions, implementation, and the limits of current evidence.
Neurology Podcast takes research off the journal page and follows it toward clinical decisions. Its interviewers ask what new evidence changes, where it applies, and what implementation will require.
Stroke guidelines become your next conversation with referring hospitals, perfusion imaging included.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear look at how Alzheimer prevention trials are moving toward practical use and wider access.
The piece follows prevention trials that are testing amyloid plaque-clearing antibodies in cognitively unimpaired people with PET or blood test evidence of amyloid plaques, and it keeps the practical stakes in view: appropriate use, cost effectiveness, insurance coverage, and…
A clear, compact look at how journal letters keep neurology research open to scrutiny and reply.
Letters to the editor can seem like a side room in a journal, but this anniversary episode treats the section as part of the main conversation.
A stroke-care update that ties guidelines, conference coverage, and bedside decision-making together.
April 2026 Recall presents a tight month of stroke-focused coverage, opening with the 2026 AHA-ASA guidelines for early management of acute ischemic stroke before moving through the 2026 International Stroke Conference and the comparison of general versus non-general anesthesia…
A clinically grounded look at headache research, spanning migraine genetics, epigenetics, comorbidities, and treatment decisions.
The Neurology Podcast's special 2026 feature on headache links recent research to the kinds of clinical decisions neurologists face when treating migraine.
A 75th-anniversary look at how letters to the editor can keep a paper's discussion alive.
Neurology's letters to the editor section gets a compact anniversary look-back as the journal marks 75 years. Jeff Ratliff leads Birch Griggs and Steve Galletta through the section's history, its shift toward a more straightforward title, and the value of correspondence as a…
Local medicine, told through physicians' lives.
Clinical oncology evidence, translated into treatment decisions.
This episode discusses a secondary analysis of the SELECT-2 trial comparing general versus non-general anesthesia for endovascular thrombectomy in patients with large core ischemic strokes.
2025 was a busy year for headache medicine.
This episode explores the history and impact of the letters to the editor section in the journal Neurology, celebrating its 75th anniversary.
This episode discusses the 2026 American Heart Association/American Stroke Association guidelines for early management of acute ischemic stroke, featuring an interview with the guideline committee chair.
John Stone, President of the Functional Neurologic Disorder Society, reviews the society’s sixth international conference in Baltimore, where 600 people registered and 200 posters presented research.
John Ney and Stacey Clardy discuss a national VA study of approximately 846,000 screened post-9/11 veterans from 2001 to 2018.
This episode features an interview with Dr.
Greg Cooper speaks with Eric Reimann about a recent Lancet Neurology policy view on preventing cognitive impairment due to Alzheimer's disease.
Neurology® Podcast marks Neurology’s 75th anniversary by examining the history and purpose of its letters to the editor section.
Two neurology professors preview the upcoming clinical trials plenary session at the AAN annual meeting, discussing how abstracts are selected and highlighting key topics without delving into specific study results.
This episode discusses a study on anti-seizure medication dosing strategies during pregnancy and postpartum for women with epilepsy, addressing clinical gaps in management.
April 2026 Recall brings the month's stroke-focused Neurology Podcast conversations together in one useful pass.
This episode reviews key developments in headache medicine from 2025, featuring an interview with neurologist Patricia Pozorosic discussing promising research areas including preclinical studies on migraine treatments.
This episode discusses the 2026 American Heart Association/American Stroke Association guidelines for early management of acute ischemic stroke, featuring an interview with the guideline committee chair.
This episode discusses a paper on outcomes after Reversible Cerebral Vasoconstriction Syndrome with convexity subarachnoid hemorrhage, exploring its diagnosis, risk factors, and differentiation from aneurysmal subarachnoid hemorrhage.